Praxis Precision Medicines shares rise 155% premarket after movement disorder drug meets main goals of two trials

jueves, 16 de octubre de 2025, 7:11 am ET1 min de lectura
PRAX--

Praxis Precision Medicines shares rise 155% premarket after movement disorder drug meets main goals of two trials

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios